Menu  → Metabolism information on chemical compounds  → 
Epicatechine
Epicatechine

Compound Epicatechine 
Animal species human intestinal bacteria Eubacterium sp. strain SDG-2 
Metabolism parameters  
Metabolites (+)-(2S 3S)-Epicatehin
(R)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol
(-)-(2R, 3S)-Epicatechin
(S)-2-(3-(3,4-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol
(S)-2-(2-hydroxy-3-(3-hydroxyphenyl)propyl)benzene-1,3,5-triol
(-)-Epigallocatechin (2R, 3R)
(S)-5-(2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl)benzene-1,2,3-triol
(S)-2-(3-(3,5-dihydroxyphenyl)-2-hydroxypropyl)benzene-1,3,5-triol
Crude drug Gambir 
References 1) Wang L., Meselhy M. R., Li Y., Nakamura N., Min B., Qin G. and Hattori M.: The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem. Pharm. Bull., 49, 1640-1643 (2001). 
Remarks ・Incubation of (+)-epicatechin with Eubacterium sp. strain SDG-2
(+)-Epicatechin (1a) (10 mg in 1 ml MeOH) was anaerobically incubated with a bacterial suspension (20 ml) for 36 h. The reaction mixture was then treated as usual to give 2a (4 mg). [Wang et al., Chem. Pharm. Bull., 49, 1640-1643 (2001)]
・Incubation of (-)-epicatechin with E. sp. strain SDG-2
(-)-Epicatechin (1b) (30 mg in 1 ml MeOH) was anaerobically incubated with a bacterial suspension for 36 h. The reaction mixture was then treated as usual to give 2b (10 mg) and 3b (8 mg), respectively. [Wang et al., Chem. Pharm. Bull., 49, 1640-1643 (2001)]
 
 

TOPICS

Information on genetic analysis

Information of bioassay

Metabolism information on chemical compounds included in crude drugs

Traditional Medical & Pharmaceutical Database


Section of Pharmacognosy,
Division of Medicinal Resources,
Department of Research and Development,
Institute of Natural Medicine,
University of Toyama
2630 Sugitani, Toyama 930-0194 Japan
TEL: +81-76-434-7601
FAX: +81-76-434-5064